| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Maria Rosaria A Muscatello, Antonio Bruno, Gianluca Pandolfo, Umberto Micò, Giuseppe Scimeca, Floriana Di Nardo, Vincenza Santoro, Edoardo Spina, Rocco A Zoccal. Effect of aripiprazole augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study. Schizophrenia research. vol 127. issue 1-3. 2011-07-01. PMID:21262565. |
effect of aripiprazole augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study. |
2011-07-01 |
2023-08-12 |
Not clear |
| Maria Rosaria A Muscatello, Antonio Bruno, Gianluca Pandolfo, Umberto Micò, Giuseppe Scimeca, Floriana Di Nardo, Vincenza Santoro, Edoardo Spina, Rocco A Zoccal. Effect of aripiprazole augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study. Schizophrenia research. vol 127. issue 1-3. 2011-07-01. PMID:21262565. |
the present 24-week double-blind, randomized, placebo-controlled trial of adjunctive aripiprazole to clozapine therapy in schizophrenia was aimed to explore the efficacy of aripiprazole add-on pharmacotherapy on clinical symptomatology and cognitive functioning in a sample of patients with treatment-resistant schizophrenia receiving clozapine. |
2011-07-01 |
2023-08-12 |
Not clear |
| Maria Rosaria A Muscatello, Antonio Bruno, Gianluca Pandolfo, Umberto Micò, Giuseppe Scimeca, Floriana Di Nardo, Vincenza Santoro, Edoardo Spina, Rocco A Zoccal. Effect of aripiprazole augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study. Schizophrenia research. vol 127. issue 1-3. 2011-07-01. PMID:21262565. |
the results obtained indicate that aripiprazole added to stable clozapine treatment showed a beneficial effect on the positive and general psychopathological symptomatology in a sample of treatment-resistant schizophrenia patients. |
2011-07-01 |
2023-08-12 |
Not clear |
| Luiz Dratcu, Patricia Olowu, Muzafar Hawramy, Charitomeni Konstantinido. Aripiprazole in the acute treatment of male patients with schizophrenia: effectiveness, acceptability, and risks in the inner-city hospital setting. Neuropsychiatric disease and treatment. vol 2. issue 2. 2011-05-17. PMID:19412463. |
aripiprazole in the acute treatment of male patients with schizophrenia: effectiveness, acceptability, and risks in the inner-city hospital setting. |
2011-05-17 |
2023-08-12 |
Not clear |
| Luiz Dratcu, Patricia Olowu, Muzafar Hawramy, Charitomeni Konstantinido. Aripiprazole in the acute treatment of male patients with schizophrenia: effectiveness, acceptability, and risks in the inner-city hospital setting. Neuropsychiatric disease and treatment. vol 2. issue 2. 2011-05-17. PMID:19412463. |
aripiprazole, a novel atypical antipsychotic that acts as a partial agonist at the dopamine d(2) receptors, has been reported to be effective in the treatment of chronic schizophrenia. |
2011-05-17 |
2023-08-12 |
Not clear |
| Luiz Dratcu, Patricia Olowu, Muzafar Hawramy, Charitomeni Konstantinido. Aripiprazole in the acute treatment of male patients with schizophrenia: effectiveness, acceptability, and risks in the inner-city hospital setting. Neuropsychiatric disease and treatment. vol 2. issue 2. 2011-05-17. PMID:19412463. |
this naturalistic study assessed the effectiveness of aripiprazole monotherapy in a group of actively psychotic male patients (n = 10) with schizophrenia who were admitted to an inner-city acute psychiatric unit. |
2011-05-17 |
2023-08-12 |
Not clear |
| Leslie Citrom. A review of aripiprazole in the treatment of patients with schizophrenia or bipolar I disorder. Neuropsychiatric disease and treatment. vol 2. issue 4. 2011-05-17. PMID:19412492. |
a review of aripiprazole in the treatment of patients with schizophrenia or bipolar i disorder. |
2011-05-17 |
2023-08-12 |
Not clear |
| Leslie Citrom. A review of aripiprazole in the treatment of patients with schizophrenia or bipolar I disorder. Neuropsychiatric disease and treatment. vol 2. issue 4. 2011-05-17. PMID:19412492. |
aripiprazole has been approved by regulatory agencies for the treatment of schizophrenia and bipolar i disorder. |
2011-05-17 |
2023-08-12 |
Not clear |
| D King, M Knapp, P Thomas, D Razzouk, J-Y Loze, H J Kan, M van Baardewij. Cost-effectiveness analysis of aripiprazole vs standard-of-care in the management of community-treated patients with schizophrenia: STAR study. Current medical research and opinion. vol 27. issue 2. 2011-05-12. PMID:21166610. |
cost-effectiveness analysis of aripiprazole vs standard-of-care in the management of community-treated patients with schizophrenia: star study. |
2011-05-12 |
2023-08-12 |
Not clear |
| D King, M Knapp, P Thomas, D Razzouk, J-Y Loze, H J Kan, M van Baardewij. Cost-effectiveness analysis of aripiprazole vs standard-of-care in the management of community-treated patients with schizophrenia: STAR study. Current medical research and opinion. vol 27. issue 2. 2011-05-12. PMID:21166610. |
abstract background: the schizophrenia trial of aripiprazole (star) showed superior efficacy for aripiprazole compared with atypical antipsychotic standard-of-care (soc) for the community treatment of schizophrenia 1 based on the investigator assessment questionnaire total score. |
2011-05-12 |
2023-08-12 |
Not clear |
| Cheng-Yuan Chen, Tai-Yueh Lin, Chia-Chun Wang, Hua-An Shua. Improvement of serum prolactin and sexual function after switching to aripiprazole from risperidone in schizophrenia: a case series. Psychiatry and clinical neurosciences. vol 65. issue 1. 2011-05-06. PMID:21265942. |
improvement of serum prolactin and sexual function after switching to aripiprazole from risperidone in schizophrenia: a case series. |
2011-05-06 |
2023-08-12 |
Not clear |
| Wakako Umene-Nakano, Reiji Yoshimura, Hikaru Hori, Tatsuya Okamoto, Jun Nakamur. A case of schizophrenia with Meige syndrome induced by long-term aripiprazole successfully treated with perospirone. Progress in neuro-psychopharmacology & biological psychiatry. vol 35. issue 1. 2011-05-03. PMID:20849906. |
a case of schizophrenia with meige syndrome induced by long-term aripiprazole successfully treated with perospirone. |
2011-05-03 |
2023-08-12 |
Not clear |
| Hidenobu Suzuki, Keishi Gen, Yuichi Inou. An unblinded comparison of the clinical and cognitive effects of switching from first-generation antipsychotics to aripiprazole, perospirone or olanzapine in patients with chronic schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry. vol 35. issue 1. 2011-05-03. PMID:21047544. |
an unblinded comparison of the clinical and cognitive effects of switching from first-generation antipsychotics to aripiprazole, perospirone or olanzapine in patients with chronic schizophrenia. |
2011-05-03 |
2023-08-12 |
human |
| Hidenobu Suzuki, Keishi Gen, Yuichi Inou. An unblinded comparison of the clinical and cognitive effects of switching from first-generation antipsychotics to aripiprazole, perospirone or olanzapine in patients with chronic schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry. vol 35. issue 1. 2011-05-03. PMID:21047544. |
the objective of this study, the effect of aripiprazole on clinical symptoms and cognitive function in patients with chronic schizophrenia was compared to that of perospirone and olanzapine. |
2011-05-03 |
2023-08-12 |
human |
| Maosheng Fang, Lehua Li, Jingping Zhao, Honghui Chen, Meng Ye, Xiaofeng Guo, Zheng Lu, Xueli Sun, Chuanyue Wang, Shiping Xie, Bin Hu, Tiansheng Guo, Cui Ma, Bo Wang, Luxian Lü, Na Liu, Hong Deng, Qi Chen, Xiaofang Shang, Fajin Gong, Xiyan Zhang, Xiaolin He, Jianchu Zhou, Yingli Zhan. [Effect of antipsychotic drugs on life quality of schizophrenic patients: one year follow-up study]. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences. vol 34. issue 9. 2011-05-02. PMID:19779255. |
to compare the effect of 7 antipsychotic drugs on the life quality of schizophrenia patients including chlorpromazine, sulpiride, clozapine, risperidone, olanzapine, quetiapine, and aripiprazole. |
2011-05-02 |
2023-08-12 |
Not clear |
| Delia Bishara, David Taylo. Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar I disorder. Neuropsychiatric disease and treatment. vol 5. 2011-04-26. PMID:19851515. |
it may be a useful alternative to aripiprazole in schizophrenia and bipolar disorder in patients who are at high risk of metabolic abnormalities. |
2011-04-26 |
2023-08-12 |
Not clear |
| Tomohiro Abekawa, Koki Ito, Shin Nakagawa, Yasuya Nakato, Tsukasa Koyam. Effects of aripiprazole and haloperidol on progression to schizophrenia-like behavioural abnormalities and apoptosis in rodents. Schizophrenia research. vol 125. issue 1. 2011-04-26. PMID:20833512. |
aripiprazole (apz) is considered a first-line medication for treating first and multiple episodes of schizophrenia, but its effect on preventing the progressive pathophysiology of schizophrenia remains unclear. |
2011-04-26 |
2023-08-12 |
Not clear |
| Giorgio L Colombo, Mauro Caruggi, Sergio Di Matteo, Alessandro Ross. An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia. Neuropsychiatric disease and treatment. vol 4. issue 5. 2011-04-21. PMID:19183788. |
an economic evaluation of aripiprazole vs olanzapine adapted to the italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia. |
2011-04-21 |
2023-08-12 |
Not clear |
| Giorgio L Colombo, Mauro Caruggi, Sergio Di Matteo, Alessandro Ross. An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia. Neuropsychiatric disease and treatment. vol 4. issue 5. 2011-04-21. PMID:19183788. |
to evaluate the cost-effectiveness of aripiprazole and olanzapine in patients with schizophrenia. |
2011-04-21 |
2023-08-12 |
Not clear |
| Haya Ascher-Svanum, Michael D Stensland, Xiaomei Peng, Douglas E Faries, Virginia L Stauffer, Olawale O Osuntokun, John M Kan. Cost-effectiveness of olanzapine vs. aripiprazole in the treatment of schizophrenia. Current medical research and opinion. vol 27. issue 1. 2011-04-01. PMID:21110749. |
cost-effectiveness of olanzapine vs. aripiprazole in the treatment of schizophrenia. |
2011-04-01 |
2023-08-12 |
Not clear |